Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
-240.37%
Operating Margin
35.85%
Net Margin
679.09%
Efficiency Metrics
Revenue per Expense Ratio
0.17
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
687.58%
Income Tax Rate
0.00%
EPS
0.7000000000
Balance Sheet Analysis
Current Ratio
1.75
Cash Ratio
1.66
Working Capital
$31.06M
Debt to Equity
0.04
Debt to Assets
4.07%
Equity Ratio
93.73%
Cash Flow Analysis
Operating Cash Flow Ratio
-105.82%
Free Cash Flow Ratio
-105.82%
CapEx to Revenue
0.00%
Dividends Paid
$149.48M
Stock Buybacks
$75.71K
Total Shareholder Returns
$149.56M
Cash Position Change
30,879.0%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
117.21%
Net Income
216.25%
EPS
204.48%
Operating Income
106.23%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
10.96%
Operating Cash Flow
-38.87%
Free Cash Flow
-38.87%
Balance Sheet Health
Assets
5.60%
Debt
21.55%
Book Value per Share
1.05%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
-1.85%
Shares Outstanding
1.90%
Long Term Trends
3Y Revenue/Share
-82.48%
5Y Revenue/Share
126.09%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%